Cargando…
Toward Novel Vaccines Against Tuberculosis: Current Hopes and Obstacles
Approximately 2 million people die of tuberculosis (TB) each year. The current vaccine, Bacille Calmette-Guérin (BCG), albeit widely employed, does not protect against adult pulmonary disease, and new vaccines are urgently needed to reduce the incidence of TB worldwide. New insights into the cellula...
Autores principales: | Thaiss, Christoph A., Kaufmann, Stefan H.E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
YJBM
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002148/ https://www.ncbi.nlm.nih.gov/pubmed/21165340 |
Ejemplares similares
-
Retina stem cells, hopes and obstacles
por: German, Olga L, et al.
Publicado: (2021) -
Recent advances towards tuberculosis control: vaccines and biomarkers
por: Weiner, J, et al.
Publicado: (2014) -
Recent developments in the epidemiology and management of tuberculosis – new solutions to old problems?
por: Thaiss, Wolfgang M, et al.
Publicado: (2012) -
Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012) -
Vaccine development against tuberculosis before and after Covid-19
por: Kaufmann, Stefan H. E.
Publicado: (2023)